- Our leadership team - Bristol Myers Squibb
Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders
- Bristol Myers Squibb’s Post - LinkedIn
Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he’ll succeed Giovanni Caforio as Chair of the Board of Directors
- Bristol Myers Squibb Appoints Christopher Boerner, Ph. D. , to Chair of . . .
Boerner was named Executive Vice President, Chief Operating Officer and CEO-elect on April 26 and, as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb
- Bristol Myers Squibb Appoints Boerner CEO Chairperson
Boerner was named executive vice president, chief operating officer and CEO-elect on April 26 and, as of Nov 1, Boerner will be CEO of Bristol Myers Squibb “I am honored to become CEO and later board chair,” said Boerner
- Bristol Myers Squibb CEO and Key Executive Team - Craft. co
Bristol Myers Squibb's Chief Executive Officer and Director is Chris Boerner Other executives include Sandra Leung, Executive Vice President, General Counsel; David Elkins, Executive Vice President and Chief Financial Officer and 47 others
- Bristol Myers Squibb CEO Christopher Boerner outlines plans - STAT
C hristopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of three acquisitions totaling $24
- Bristol Myers Squibb Appoints Christopher Boerner as Chief Executive . . .
Bristol Myers Squibb announced that Christopher Boerner, Ph D , as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb About Christopher Boerner, Ph D : Christopher Boerner has served as EVP, Chief Operating Officer and CEO-elect since April 26, 2023
- Bristol Myers Squibb appoints new CEO - European Pharmaceutical Review
Christopher Boerner, PhD, Executive Vice President (EVP), Chief Commercialization Officer of Bristol Myers Squibb will become the company’s new CEO on November 1 2023 Effective immediately, Boerner has been named its EVP, Chief Operating Officer
|